2016
DOI: 10.1016/j.joca.2016.03.009
|View full text |Cite
|
Sign up to set email alerts
|

Neo-cartilage engineered from primary chondrocytes is epigenetically similar to autologous cartilage, in contrast to using mesenchymal stem cells

Abstract: In vitro engineered neo-cartilage tissue from primary chondrocytes, hPACs, exhibits a DNA methylation landscape that is almost identical (99% similarity) to autologous cartilage, in contrast to neo-cartilage engineered from bone marrow-derived mesenchymal stem cells (MSCs). Although hBMSCs are widely used for cartilage engineering purposes the effects of these vast differences on cartilage regeneration and long term consequences of implantation, are not known. The use of hBMSCs or hPACs for future cartilage ti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
28
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(33 citation statements)
references
References 49 publications
(44 reference statements)
4
28
1
Order By: Relevance
“…By RBBS only limited changes in promoter methylation were identified during MSC chondrogenesis in a 3D alginate model (Herlofsen et al , 2013), but more recently by Infinium 450K methylation array 1116 differentially methylated CpGs were identified across a timecourse of chondrogenic differentiation in a pellet model, albeit starting at Dayl4 (to Day49) in contrast to our comparison of undifferentiated vs. differentiated cells (Day0 vs. Dayl4) (Bomer et al , 2016). The vast majority of differentially methylated CpGs during chondrogenesis herein become hypomethylated indicative of a loss of repression at these locations.…”
Section: Discussionmentioning
confidence: 56%
See 1 more Smart Citation
“…By RBBS only limited changes in promoter methylation were identified during MSC chondrogenesis in a 3D alginate model (Herlofsen et al , 2013), but more recently by Infinium 450K methylation array 1116 differentially methylated CpGs were identified across a timecourse of chondrogenic differentiation in a pellet model, albeit starting at Dayl4 (to Day49) in contrast to our comparison of undifferentiated vs. differentiated cells (Day0 vs. Dayl4) (Bomer et al , 2016). The vast majority of differentially methylated CpGs during chondrogenesis herein become hypomethylated indicative of a loss of repression at these locations.…”
Section: Discussionmentioning
confidence: 56%
“…In contrast DNA methylation at gene promoters, assessed by reduced representation bisulfite sequencing (RBBS), did not correlate with gene expression (Herlofsen et al , 2013). Utilising the Infinium 450K methylation array the effect of ageing on cartilage DNA methylation and the similarity between MSC-derived cartilage methylation in comparison with cartilage engineered from articular chondrocytes have been studied (Bomer et al , 2016; Peffers et al , 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Cartilage tissue engineering is no exception, and hence large scale expansion of chondrocytes is required either for novel scaffold testing, determination of potential cytotoxic effects of medical devices and implants for orthopaedic use (Bomer et al, 2016; Camarero-Espinosa et al, 2016; Makris et al, 2015). Cultivation of such high cell counts is a demanding task, especially considering the low number of obtained cells in the primary culture, and an often limited amount of available tissue.…”
Section: Discussionmentioning
confidence: 99%
“…Over the past decade a number of viable options of cartilage regeneration have been introduced into clinical practice (Camarero-Espinosa et al, 2016; Hettrich, Crawford & Rodeo, 2008; Schrobback et al, 2011). Among these, autologous chondrocyte implantation (ACI) seems the most promising since it relies on the use of biodegradable materials that serve as temporary cell-carriers, enabling in vitro cell growth and subsequent implantation into the defective cartilage (Bomer et al, 2016; Niemeyer et al, 2016; Robb et al, 2012). …”
Section: Introductionmentioning
confidence: 99%
“…Primary chondrocytes were isolated from three independent donors and passaged twice or thrice, as described in [23]. Chondrocytes were transfected in duplo with antisense locked nucleic acid (LNA) GapmeR (Qiagen) targeting P3H2-AS1 (TGAGCAACTAGGTGTA) or GapmeR negative control (AACACGTCTATACGC) at 10 nM final concentration using Lipofectamine RNAiMax Transfection Reagent (Invitrogen) according to manufacturer's protocol.…”
Section: In Vitro Downregulation Lncrna Using Locked Nucleic Acid Gapmentioning
confidence: 99%